Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities Miscellaneous news Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities AETOSWire sarjatha 11 May، 2023 SALT LAKE CITY and TORONTO and MONTRÉAL — Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding...Read More